MedPath

Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea

Not Applicable
Completed
Conditions
Acne Vulgaris and Rosacea
Interventions
Device: Long-pulsed dye laser (Candela) and PDT (methylaminolevulinate)
Device: Long-pulsed dye laser
Device: Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate)
Registration Number
NCT00483145
Lead Sponsor
Bispebjerg Hospital
Brief Summary

To evaluate efficacy and adverse effect from long-pulsed dye laser versus long-pulsed dye laser-mediated photodynamic therapy for acne vulgaris and rosacea.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Inflammatory acne and rosacea
  • Skin types I-IV
Exclusion Criteria
  • Patients younger than 18 years
  • Skin types V and VI
  • Topical and systemic conventional acne treatments

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1Long-pulsed dye laser (Candela) and PDT (methylaminolevulinate)Long-pulsed dye laser (Candela)
1Long-pulsed dye laserLong-pulsed dye laser (Candela)
2Long-pulsed dye laser (Candela) and PDT (methylaminolevulinate)Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate)
2Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate)Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate)
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Bispebjerg Hospital

🇩🇰

Copenhagen NV, Denmark

© Copyright 2025. All Rights Reserved by MedPath